TVTX logo

Travere Therapeutics, Inc. (TVTX) Net Income

Annual Net Income:

-$320.63M+$55.70M(+14.80%)
December 31, 2024

Summary

  • As of today, TVTX annual net profit is -$320.63 million, with the most recent change of +$55.70 million (+14.80%) on December 31, 2024.
  • During the last 3 years, TVTX annual net income has fallen by -$140.54 million (-78.04%).
  • TVTX annual net income is now -373.49% below its all-time high of $117.24 million, reached on December 31, 2015.

Performance

TVTX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

Quarterly Net Income:

-$12.76M+$28.47M(+69.06%)
June 30, 2025

Summary

  • As of today, TVTX quarterly net profit is -$12.76 million, with the most recent change of +$28.47 million (+69.06%) on June 30, 2025.
  • Over the past year, TVTX quarterly net income has increased by +$56.90 million (+81.69%).
  • TVTX quarterly net income is now -112.08% below its all-time high of $105.58 million, reached on September 30, 2015.

Performance

TVTX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

TTM Net Income:

-$169.00M+$56.90M(+25.19%)
June 30, 2025

Summary

  • As of today, TVTX TTM net profit is -$169.00 million, with the most recent change of +$56.90 million (+25.19%) on June 30, 2025.
  • Over the past year, TVTX TTM net income has increased by +$214.45 million (+55.93%).
  • TVTX TTM net income is now -244.15% below its all-time high of $117.24 million, reached on December 31, 2015.

Performance

TVTX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TVTX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+14.8%+81.7%+55.9%
3Y3 Years-78.0%+81.0%+26.6%
5Y5 Years-119.0%+51.1%-116.5%

TVTX Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-78.0%+14.8%at high+90.6%at high+57.7%
5Y5-Year-119.0%+14.8%at high+90.6%-116.5%+57.7%
All-TimeAll-Time-373.5%+14.8%-112.1%+90.6%-244.2%+57.7%

TVTX Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$12.76M(+69.1%)
-$169.00M(+25.2%)
Mar 2025
-
-$41.23M(+31.6%)
-$225.90M(+29.5%)
Dec 2024
-$320.63M(+14.8%)
-$60.27M(-10.1%)
-$320.63M(+8.1%)
Sep 2024
-
-$54.75M(+21.4%)
-$348.96M(+9.0%)
Jun 2024
-
-$69.65M(+48.8%)
-$383.45M(+4.0%)
Mar 2024
-
-$135.96M(-53.5%)
-$399.43M(-10.9%)
Dec 2023
-$376.33M(-13.5%)
-$88.60M(+0.7%)
-$360.03M(-0.8%)
Sep 2023
-
-$89.24M(-4.2%)
-$357.07M(-1.5%)
Jun 2023
-
-$85.63M(+11.3%)
-$351.89M(-5.6%)
Mar 2023
-
-$96.56M(-12.8%)
-$333.30M(-6.6%)
Dec 2022
-$331.47M(-84.1%)
-$85.64M(-1.9%)
-$312.70M(-12.2%)
Sep 2022
-
-$84.06M(-25.4%)
-$278.64M(-21.0%)
Jun 2022
-
-$67.03M(+11.8%)
-$230.22M(-13.9%)
Mar 2022
-
-$75.97M(-47.3%)
-$202.19M(-12.3%)
Dec 2021
-$180.09M(-6.3%)
-$51.57M(-44.7%)
-$180.09M(+28.0%)
Sep 2021
-
-$35.64M(+8.6%)
-$250.14M(-5.5%)
Jun 2021
-
-$39.01M(+27.6%)
-$237.05M(-5.8%)
Mar 2021
-
-$53.87M(+55.7%)
-$224.11M(-32.3%)
Dec 2020
-$169.43M(-15.7%)
-$121.62M(-439.4%)
-$169.43M(-117.0%)
Sep 2020
-
-$22.55M(+13.5%)
-$78.07M(+15.2%)
Jun 2020
-
-$26.07M(-3326.2%)
-$92.01M(+12.1%)
Mar 2020
-
$808.00K(+102.7%)
-$104.64M(+28.5%)
Dec 2019
-$146.43M(-42.6%)
-$30.26M(+17.1%)
-$146.43M(-18.4%)
Sep 2019
-
-$36.49M(+5.7%)
-$123.62M(+12.7%)
Jun 2019
-
-$38.70M(+5.6%)
-$141.65M(-13.1%)
Mar 2019
-
-$40.98M(-449.7%)
-$125.28M(-22.0%)
Dec 2018
-$102.68M(-71.9%)
-$7.46M(+86.3%)
-$102.68M(+9.0%)
Sep 2018
-
-$54.52M(-144.1%)
-$112.84M(-48.2%)
Jun 2018
-
-$22.33M(-21.5%)
-$76.12M(-13.6%)
Mar 2018
-
-$18.38M(-4.3%)
-$67.02M(-12.2%)
Dec 2017
-$59.73M
-$17.62M(+1.0%)
-$59.73M(-17.8%)
Sep 2017
-
-$17.79M(-34.5%)
-$50.72M(+27.6%)
Jun 2017
-
-$13.23M(-19.3%)
-$70.03M(+0.2%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$11.09M(-28.9%)
-$70.21M(-46.6%)
Dec 2016
-$47.90M(-140.9%)
-$8.60M(+76.8%)
-$47.90M(-14.7%)
Sep 2016
-
-$37.11M(-176.9%)
-$41.77M(-141.4%)
Jun 2016
-
-$13.40M(-219.5%)
$100.92M(+13.7%)
Mar 2016
-
$11.22M(+554.3%)
$88.80M(-24.3%)
Dec 2015
$117.24M(+205.7%)
-$2.47M(-102.3%)
$117.24M(+29.3%)
Sep 2015
-
$105.58M(+513.6%)
$90.68M(+363.2%)
Jun 2015
-
-$25.53M(-164.4%)
-$34.46M(-7632.4%)
Mar 2015
-
$39.66M(+236.6%)
-$445.60K(+99.6%)
Dec 2014
-$110.94M(-220.4%)
-$29.03M(-48.4%)
-$110.73M(-17.1%)
Sep 2014
-
-$19.56M(-330.5%)
-$94.52M(-10.1%)
Jun 2014
-
$8.48M(+112.0%)
-$85.86M(+13.6%)
Mar 2014
-
-$70.63M(-450.8%)
-$99.39M(-196.6%)
Dec 2013
-$34.62M(-14.1%)
-$12.82M(-17.7%)
-$33.51M(+34.3%)
Sep 2013
-
-$10.90M(-115.9%)
-$51.02M(-27.2%)
Jun 2013
-
-$5.05M(-6.4%)
-$40.12M(-14.4%)
Mar 2013
-
-$4.74M(+84.4%)
-$35.08M(-15.6%)
Dec 2012
-$30.34M(>-9900.0%)
-$30.33M(>-9900.0%)
-$30.33M(>-9900.0%)
Nov 2011
-
-$3500.00(0.0%)
-$14.60K(+13.1%)
Aug 2011
-
-$3500.00(0.0%)
-$16.80K(+15.6%)
May 2011
-
-$3500.00(+14.6%)
-$19.90K(+13.5%)
Feb 2011
-$23.00K(+17.9%)
-$4100.00(+28.1%)
-$23.00K(+11.2%)
Nov 2010
-
-$5700.00(+13.6%)
-$25.90K(+3.4%)
Aug 2010
-
-$6600.00(0.0%)
-$26.80K(+0.4%)
May 2010
-
-$6600.00(+5.7%)
-$26.90K(+3.6%)
Feb 2010
-$28.00K(-53.0%)
-$7000.00(-6.1%)
-$27.90K(+2.1%)
Nov 2009
-
-$6600.00(+1.5%)
-$28.50K(-8.8%)
Aug 2009
-
-$6700.00(+11.8%)
-$26.20K(-15.9%)
May 2009
-
-$7600.00(0.0%)
-$22.60K(-22.8%)
Feb 2009
-$18.30K(+64.8%)
-$7600.00(-76.7%)
-$18.40K(-70.4%)
Nov 2008
-
-$4300.00(-38.7%)
-$10.80K(-66.2%)
Aug 2008
-
-$3100.00(+8.8%)
-$6500.00(-91.2%)
May 2008
-
-$3400.00
-$3400.00
Feb 2008
-$52.00K
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual net profit?
  • What is the all-time high annual net income for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual net income year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Travere Therapeutics, Inc. TTM net profit?
  • What is the all-time high TTM net income for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM net income year-on-year change?

What is Travere Therapeutics, Inc. annual net profit?

The current annual net income of TVTX is -$320.63M

What is the all-time high annual net income for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual net profit is $117.24M

What is Travere Therapeutics, Inc. annual net income year-on-year change?

Over the past year, TVTX annual net profit has changed by +$55.70M (+14.80%)

What is Travere Therapeutics, Inc. quarterly net profit?

The current quarterly net income of TVTX is -$12.76M

What is the all-time high quarterly net income for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly net profit is $105.58M

What is Travere Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, TVTX quarterly net profit has changed by +$56.90M (+81.69%)

What is Travere Therapeutics, Inc. TTM net profit?

The current TTM net income of TVTX is -$169.00M

What is the all-time high TTM net income for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM net profit is $117.24M

What is Travere Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, TVTX TTM net profit has changed by +$214.45M (+55.93%)
On this page